(1)
Gottlieb, A. B.; Strober, B.; Tha?i, D.; Gordon, K.; Kundu, S.; Kisa, R.; Wei, L.; Banerjee, S.; Merola, J. BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis As Assessed by the Static Physician’s Global Assessment (sPGA)/Body Surface Area (BSA) Composite Tool (sPGAxBSA), a Clinically Useful Alternative to PASI. J of Skin 2020, 4, s29.